Related Experiment Videos
Arthritis and hematological changes induced by an analogue of muramyl dipeptide in rats
T Sugawara1, M Kato, S Takayama
1Drug Safety Research Center, Daiichi Pharmaceutical Co., Ltd., Tokyo, Japan.
Abstract:
We examined changes of blood cell counts and development of arthritis induced by daily subcutaneous injections of MDP-Lys(L18), an analogue of muramyl dipeptide (MDP), in rats. The numbers of neutrophils markedly increased in the peripheral blood 4 hr after the 1st, 7th, and 14th administrations of MDP-Lys(L18), but they recovered to the control levels within 24 hr. Monocyte and lymphocyte counts increased after the 7th and 14th administrations, respectively, although both decreased after the 1st dosing. Serum inflammatory markers, such as albumin, globulin, mucoprotein, sialic acid, and iron, showed marked changes after the 1st administration. Histopathologically, the synovial membrane of the tarsal joint showed a multilayer arrangement of synoviocytes with vesicular cytoplasms and infiltration of neutrophils from 6 hr after the 1st administration of the drug. The acute synovitis was gradually enhanced until 24 hr later. The synovitis was greatly decreased in degree after the 3rd administration, but increased again later. After the 7th and 14th administrations, mononuclear cells and lymphocytes, respectively, infiltrated the synovial membrane, in a manner corresponding to the hematological findings. However, exudative changes and neutrophilic infiltration were still observed after the 14th drug administration, and the synovitis was repaired after a 7-day recovery period.
Insights
Muramyl dipeptide analogue (MDP-Lys(L18)) induced neutrophil and monocyte increases in rats, alongside acute synovitis. Arthritis symptoms fluctuated but persisted after repeated dosing, showing repair post-recovery.
Area of Science:
- Immunology
- Rheumatology
- Pharmacology
Background:
- Muramyl dipeptide (MDP) analogues are studied for their immunomodulatory effects.
- Understanding the impact of MDP-Lys(L18) on inflammatory responses is crucial.
Purpose of the Study:
- To investigate the effects of MDP-Lys(L18) on blood cell counts and arthritis development in rats.
- To characterize the histopathological changes in joint tissues.
Main Methods:
- Rats received daily subcutaneous injections of MDP-Lys(L18).
- Blood cell counts and serum inflammatory markers were analyzed.
- Histopathological examination of synovial membranes was performed.
Main Results:
- MDP-Lys(L18) caused transient increases in neutrophils and monocytes, with fluctuations in lymphocytes.
- Serum inflammatory markers showed significant changes after initial administration.
- Acute synovitis developed, characterized by neutrophilic infiltration, with varying severity after repeated doses.
Conclusions:
- MDP-Lys(L18) triggers acute inflammatory responses and synovitis in rats.
- Repeated administration leads to complex changes in immune cell infiltration and synovitis.
- Joint tissues showed signs of repair after a recovery period.